Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Chinese Patent Office
Colorcon
McKesson
UBS
Covington

Generated: August 19, 2019

DrugPatentWatch Database Preview

Patent: 9,650,433

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,650,433
Title:Modified glycoproteins
Abstract: Sulfated glycoproteins, and methods of making and using such sulfated glycoproteins, are described.
Inventor(s): Bulik; Dorota A. (Malden, MA), Bosques; Carlos J. (Arlington, MA), Collins; Brian Edward (Arlington, MA), Hains; Maurice Gaston (Brockton, MA), Washburn; Nathaniel J. (Littleton, MA), Meador; James (Framingham, MA), Smith; Sean (Littleton, MA), Bhatnagar; Naveen (Framingham, MA)
Assignee: Momenta Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:14/118,269
Patent Claims:see list of patent claims

Details for Patent 9,650,433

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Biogen ZINBRYTA daclizumab INJECTABLE;INJECTION 761029 001 2016-05-27   Try a Free Trial Momenta Pharmaceuticals, Inc. (Cambridge, MA) 2031-05-20 RX search
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16   Try a Free Trial Momenta Pharmaceuticals, Inc. (Cambridge, MA) 2031-05-20 RX Orphan search
Genentech LUCENTIS ranibizumab INJECTABLE; INJECTION 125156 001 2006-06-30   Try a Free Trial Momenta Pharmaceuticals, Inc. (Cambridge, MA) 2031-05-20 RX search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 003 2006-09-27   Try a Free Trial Momenta Pharmaceuticals, Inc. (Cambridge, MA) 2031-05-20 RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
UBS
Daiichi Sankyo
McKinsey
AstraZeneca
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.